Evidence-Based Pediatric Oncology

Ross Pinkerton Mater Hospitals, Raymond Terrace, Brisbane, Australia AG Shankar Department of Paediatric and Adolescent Oncology, University College of London NHS Trust, London, UK Katherine Matthay Department of Pediatric Oncology, University of California at San Francisco, CA, USA

Introduction. Ross Pinkerton. Part 1: Solid Tumors. Ross Pinkerton. 1 Rhabdomyosarcoma. Commentary by Michael Stevens and Meriel Jenney. 2 Osteosarcoma. Commentary by Alan Craft. 3 Ewing's sarcoma. Commentary by Alan Craft. 4 Wilms' tumor. Commentary by Daniel Green. 5 Neuroblastoma. Commentary by Katherine Matthay. 6 Hepatoblastoma and malignant germ-cell tumors. Commentary by Ross Pinkerton. 7 Medulloblastoma. Commentary by Joann Ater. 8 Glioma. Commentary by Joann Ater. 9 Non-Hodgkin's lymphoma. Commentary by Tim Eden and Ross Pinkerton. 10 Hodgkin's disease. Commentary by Tim Eden and Ross Pinkerton. Part 2: Leukemia. AG Shankar. Acute myeloid leukemia. Commentaries by Judith Chessells and Vaskar Saha. 11 Induction regimens in acute myeloid leukemia. 12 Role of autologous BMT in children with acute myeloid leukemia in first remission. 13 Role of maintenance treatment in childhood acute myeloid leukemia. Childhood lymphoblastic leukemia. Commentaries by Vaskar Saha and Judith Chessells. 14 Steroids and asparaginases during remission induction therapy in childhood lymphoblastic leukemia. 15 CNS prophylaxis in childhood lymphoblastic leukemia. 16 Continuing therapy in childhood lymphoblastic leukemia - duration of continuing therapy. Part 3: Supportive Care in Pediatric Oncology. Katherine Matthay and AG Shankar. 17 Use of hemopoietic colony stimulating factors (G-CSF, G-MCSF and erythropoietin). 18 Cardioprotection in pediatric oncology. Index